145 related articles for article (PubMed ID: 25348318)
1. Functional analysis of HPV-like particle-activated Langerhans cells in vitro.
Yan L; Woodham AW; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():333-50. PubMed ID: 25348318
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.
Woodham AW; Raff AB; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():135-49. PubMed ID: 25348303
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses.
Fausch SC; Da Silva DM; Rudolf MP; Kast WM
J Immunol; 2002 Sep; 169(6):3242-9. PubMed ID: 12218143
[TBL] [Abstract][Full Text] [Related]
4. Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.
Fausch SC; Da Silva DM; Kast WM
Vaccine; 2005 Feb; 23(14):1720-9. PubMed ID: 15705478
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.
Da Silva DM; Woodham AW; Naylor PH; Egan JE; Berinstein NL; Kast WM
J Interferon Cytokine Res; 2016 May; 36(5):291-301. PubMed ID: 26653678
[TBL] [Abstract][Full Text] [Related]
6. Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections.
Leong CM; Doorbar J; Nindl I; Yoon HS; Hibma MH
J Invest Dermatol; 2010 Feb; 130(2):472-80. PubMed ID: 19759549
[TBL] [Abstract][Full Text] [Related]
7. EpCAM Expressed by Murine Epidermal Langerhans Cells Modulates Immunization to an Epicutaneously Applied Protein Antigen.
Ouchi T; Nakato G; Udey MC
J Invest Dermatol; 2016 Aug; 136(8):1627-1635. PubMed ID: 27106675
[TBL] [Abstract][Full Text] [Related]
8. Isolation of immature primary Langerhans cells from human epidermal skin.
de Jong MA; de Witte L; Geijtenbeek TB
Methods Mol Biol; 2010; 595():55-65. PubMed ID: 19941105
[TBL] [Abstract][Full Text] [Related]
9. Langerhans Cells From Mice at Birth Express Endocytic- and Pattern Recognition-Receptors, Migrate to Draining Lymph Nodes Ferrying Antigen and Activate Neonatal T Cells
Becerril-García MA; Yam-Puc JC; Maqueda-Alfaro R; Beristain-Covarrubias N; Heras-Chavarría M; Gallegos-Hernández IA; Calderón-Amador J; Munguía-Fuentes R; Donis-Maturano L; Flores-Langarica A; Flores-Romo L
Front Immunol; 2020; 11():744. PubMed ID: 32395120
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation.
Fausch SC; Fahey LM; Da Silva DM; Kast WM
J Immunol; 2005 Jun; 174(11):7172-8. PubMed ID: 15905561
[TBL] [Abstract][Full Text] [Related]
11. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response.
Fukunaga A; Khaskhely NM; Sreevidya CS; Byrne SN; Ullrich SE
J Immunol; 2008 Mar; 180(5):3057-64. PubMed ID: 18292528
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.
Bomsel M; Ganor Y
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904199
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells in allergic contact dermatitis.
Tuchinda P; Gaspari AA
G Ital Dermatol Venereol; 2010 Dec; 145(6):747-62. PubMed ID: 21139551
[TBL] [Abstract][Full Text] [Related]
14. Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
Fahey LM; Raff AB; Da Silva DM; Kast WM
J Immunol; 2009 Mar; 182(5):2919-28. PubMed ID: 19234187
[TBL] [Abstract][Full Text] [Related]
15. Viruses and Langerhans cells.
Cunningham AL; Abendroth A; Jones C; Nasr N; Turville S
Immunol Cell Biol; 2010; 88(4):416-23. PubMed ID: 20445632
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.
Da Silva DM; Movius CA; Raff AB; Brand HE; Skeate JG; Wong MK; Kast WM
Virology; 2014 Mar; 452-453():279-86. PubMed ID: 24606705
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.
Iijima N; Goodwin EC; Dimaio D; Iwasaki A
Virology; 2013 Sep; 444(1-2):257-62. PubMed ID: 23871219
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
Cooper KD; Androphy EJ; Lowy D; Katz SI
J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366
[TBL] [Abstract][Full Text] [Related]
19. HPV binding assay to Laminin-332/integrin α6β4 on human keratinocytes.
Brendle SA; Christensen ND
Methods Mol Biol; 2015; 1249():53-66. PubMed ID: 25348297
[TBL] [Abstract][Full Text] [Related]
20. Multistep navigation of Langerhans/dendritic cells in and out of the skin.
Jakob T; Ring J; Udey MC
J Allergy Clin Immunol; 2001 Nov; 108(5):688-96. PubMed ID: 11692090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
